FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Market Closed - Börse Stuttgart 20:28:30 30/05/2024 BST | ||
| 10.76 EUR | +1.03% |
|
| Current month | +4.87% | ||
| 1 month | +4.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 30/05/24 | 10.76 | +1.03% |
| 29/05/24 | 10.65 | +0.95% |
| 28/05/24 | 10.55 | +6.03% |
| 27/05/24 | 9.95 | -0.90% |
| 24/05/24 | 10.04 | +2.14% |
Delayed Quote Börse Stuttgart
Last update May 30, 2024 at 08:28 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MG1SPQ |
| ISIN | DE000MG1SPQ1 |
| Date issued | 05/04/2024 |
| Strike | 188.9 $ |
| Maturity | Unlimited |
| Parity | 5.49 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.04 € |
|---|---|
| Lowest since issue | 9.57 € |
| Spread | 0.01 € |
| Spread % | 0.09% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
124.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.93%
- Stock Market
- Certificates
- Certificat
